ArticleJournal of clinical medicine2025

Real-World Experience with Pasireotide-LAR in Cushing's Disease: Single-Center 12-Month Observational Study.

Lukasz Dzialach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.